Results 131 to 140 of about 909,959 (264)
Molecular Pathology of Pancreatic Ductal Adenocarcinoma. [PDF]
Shalaby A, Sadri N, Xue Y.
europepmc +1 more source
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi +6 more
wiley +1 more source
Special Issue "Melanoma: From Molecular Pathology to Therapeutic Approaches". [PDF]
Eccles MR.
europepmc +1 more source
RoboMic is an automated confocal microscopy pipeline for high‐throughput functional imaging in living cells. Demonstrated with fluorescence recovery after photobleaching (FRAP), it integrates AI‐driven nuclear segmentation, ROI selection, bleaching, and analysis.
Selçuk Yavuz +6 more
wiley +1 more source
Molecular Pathology of Advanced NSCLC: Biomarkers and Therapeutic Decisions. [PDF]
Winter M +4 more
europepmc +1 more source
This study investigated a novel WST‐8‐based assay for evaluating d‐Amino acid oxidase (DAO) inhibitors. We confirmed its effectiveness using known inhibitors and found that uremic toxins possess relatively weak inhibitory activity compared to existing drugs.
Kahoko Miyake +4 more
wiley +1 more source
Editorial: Molecular Pathology of HTLV-1
Umberto Bertazzoni +3 more
doaj +1 more source
Focused Ultrasound for the Treatment of Circuit and Molecular Pathology in Parkinson's Disease. [PDF]
Kofoed RH +7 more
europepmc +1 more source
A novel signature integrating genome‐wide analysis with clinical factors predicts recurrence in stage II colorectal cancer and enables a new risk stratification to guide postoperative adjuvant chemotherapy. Clinical risk stratification for postoperative recurrence in patients with pathological stage II (pStage II) colorectal cancer (CRC) is essential ...
Mayuko Otomo +7 more
wiley +1 more source
Validation of a Mass Spectrometry-Based Proteomics Molecular Pathology Assay. [PDF]
Chapman JR +9 more
europepmc +1 more source

